Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-02-22
2009-08-18
Desai, Rita J (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S377000, C544S062000, C514S218000, C514S217030, C514S228200, C540S575000, C540S596000
Reexamination Certificate
active
07576088
ABSTRACT:
The present invention relates to compounds of the general formulaand pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases such as obesity by selective modulation of CB1 receptors.
REFERENCES:
patent: 5624941 (1997-04-01), Barth et al.
patent: 6432984 (2002-08-01), Barth et al.
patent: 2001/0034344 (2001-10-01), Mittendorf et al.
patent: 2002/0019383 (2002-02-01), Achard et al.
patent: 0216831 (1987-08-01), None
patent: 576357 (1995-06-01), None
patent: 656354 (1995-06-01), None
patent: 658546 (1995-06-01), None
patent: 761673 (1997-03-01), None
patent: 2 789 078 (2000-08-01), None
patent: WO 92 18490 (1992-10-01), None
patent: WO9719063 (1997-05-01), None
patent: WO0015609 (2000-03-01), None
patent: WO0046209 (2000-08-01), None
patent: WO 01 28557 (2001-04-01), None
patent: WO 01 29007 (2001-04-01), None
patent: WO0132663 (2001-05-01), None
patent: WO0158869 (2001-08-01), None
patent: WO0164632 (2001-09-01), None
patent: WO0164633 (2001-09-01), None
patent: WO0164634 (2001-09-01), None
patent: WO0224630 (2002-03-01), None
patent: WO0228346 (2002-04-01), None
patent: WO 02 36590 (2002-05-01), None
patent: WO 02 42248 (2002-05-01), None
Pozharskii et. al. Heterocycles in Life and Society Wiley, 1997, pp. 1-6.
P. H. Reggio “Endocannabinoid structure-activity relationships for interaction at the cannabinoid receptors” Prostaglandins, Leukotrienes and Essential Fatty Acids 2002, 66, 143-160.
Martin, Yvonne C. et. al. “Do Structurally Similar Molecules Have Similar Biological Activity?” Journal of Medicinal Chemistry 2002, 45, 4350-4358.
Lea W. Padgett “Recent developments in cannabinoid ligands” Life Sciences 2005, 77, 1767-1798.
D. Shire, et. al, J. Biol. Chem. 270 (8) (1995) 3726-31.
S. Munro, et. al. Nature 365 (1993) 61-61.
Y. Gaoni, et. al. J. Am. Chem. Soc, 86 (1964) 16.
R. Mechoulam (Ed.) in “Cannabinoids as therapeutic Agents”, (1986), pp. 1-20, CRC Pr.
E.M. Williamson, F. J. Evans, Drugs 60 (6) (2000) 1303-1314.
R. G. Pertwee, Curr. Med. Chem., 6 (8) (1999) 635-664.
W.A. Devane, et. al. Science 258 (1992) 1946-9.
V. Di Marzo, et. al., Trends in Neuroscience 21 (12) (1998) 521-8.
A.C. Porter, C.C. Felder, Pharmacol. Ther., 90 (1) (2001) 45-60.
C.M. Williams, T.C. Kirkham, Psychopharmacology 143 (3) (1999) 315-317.
C.C. Felder, et. al., Proc. Natl. Acad. Sci. USA 90 (16) (1993) 7656-7660.
G. Colombo, et. al., Life Sci. 63 (8) (1998) L113-PL117.
V. Di Marzo, et. al., Nature 410 (6830) 822-825.
F. Barth, et. al. “Cannabinoid antagonists: From research tools to potential new drugs”, Abstracts of Papers, 222ndACS National Meeting, Chicago, IL, United States, Aug. 26-30, 2001.
AAI; M. Pacheco, et. al. Exp. Ther. 257 (1) (1991) 170-183.
F.M. Casiano, et. al. NIDA Res. Monogr. 105 (1991) 295-6.
AM630, K. Hosohata, et. al. Life. Sci 61 (1997) 115-118.
R. Pertwee, et. al., Life Sci. 56 (23-24) (1995) 1949-55.
LY320135, C.C. Felder, et. al., J. Pharmacol. Exp. Ther. 284, (1) (1998) 291-297 disclosed in WO9602248.
M. Kanyonyo, et. al., Bioorg. Med. Chem. Lett. 9 (15) (1999) 2233-2236.
F. Ooms, et. al., J. Med. Chem. 45 (9) (2002) 1748-1756.
Patent Abstracts of Japan, vol. 015, No. 001, (1991) & JP 02 0255673 A., Fuji Photo File Co Ltd, (1990).
Alanine Alexander
Bleicher Konrad
Guba Wolfgang
Haap Wolfgang
Kube Dagmar
Desai Rita J
Hoffman-La Roche Inc.
Johnston George W.
O'Dell David K
Remy Brian C.
LandOfFree
Benzodioxole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzodioxole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzodioxole derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4138282